PDCT-06. RADIO-IMMUNOTHERAPY USING THE IDO-INHIBITOR INDOXIMOD IN COMBINATION WITH RE-IRRADIATION FOR CHILDREN WITH PROGRESSIVE BRAIN TUMORS IN THE PHASE 1 SETTING: AN UPDATED REPORT OF SAFETY AND TOLERABILITY (NCT02502708)

Saved in:
Bibliographic Details
Published in:Neuro-oncology (Charlottesville, Va.) Va.), 2017-11, Vol.19 (suppl_6), p.vi185-vi185
Main Authors: Johnson, Theodore S, Aguilera, Dolly, Al-Basheer, Ahmad, Cooksey, Raven M, Eaton, Bree R, Esiashvili, Natia, Firat, Selim, Fiveash, John B, Foreman, Nicholas, Fridlyand, Diana, Friedman, Gregory K, Giller, Cole A, Grosshans, David R, Heger, Ian M, Kelly, Michael, Kennedy, Eugene P, Knipstein, Jeffrey, Kolhe, Ravindra B, Liu, Arthur K, Martin, William, Mourad, Waleed F, Pacholczyk, Rafal, Parker, Rebecca, Rojiani, Amyn M, Sadek, Ramses F, Thornton, Allan, Vahanian, Nicholas N, MacDonald, Tobey, Munn, David
Format: Article
Language:English
Subjects:
Abstracts
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1522-8517
1523-5866
DOI:10.1093/neuonc/nox168.750